AA
AKAO

ALPS Advisors’s Achaogen Inc AKAO Stock Holding History

ALPS Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-41,593
Closed -$663K – 900
2017
Q3 		$663K Buy
41,593
+4,725
+13% +$89.9K ﹤0.01% 321
2017
Q2 		$801K Buy
+36,868
New +$842K 0.01% 264

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

ALPS Advisors's AKAO Position: Q4 2017 in Review

ALPS Advisors sold out of Achaogen Inc (AKAO) in Q4 2017, closing a stake of 41,593 shares — an estimated $663K sold.

ALPS Advisors first reported a position in AKAO in Q2 2017 and held it in 2 quarters. The position peaked at $801K in Q2 2017. 103 funds tracked by Wall St. Rank hold AKAO as of Q4 2017.

  • ALPS Advisors reported no remaining Achaogen Inc position as of Q4 2017 after selling out during the quarter.
  • ALPS Advisors sold 41,593 Achaogen Inc shares in Q4 2017, an estimated $663K.
  • ALPS Advisors first reported a position in Achaogen Inc in Q2 2017 and held it in 2 quarters.
  • ALPS Advisors's Achaogen Inc position peaked at $801K in Q2 2017.
  • 103 funds tracked by Wall St. Rank held Achaogen Inc as of Q4 2017.

Based on ALPS Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.